These findings provide new insights into the role of RSV in hepatic cells and its potential adverse effects on the liver when utilized as a supplement to treat InsR and other related liver metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD) [173]. This evidence concerns the gene INSR and metabolic dysfunction-associated steatotic liver disease.